The proposed 100% US tariffs on certain pharmaceuticals raise concerns about uncertainty in US–Taiwan trade relations. Any exclusion from preferential treatment could have broader implications. TaiwanPlus spoke with Darson Chiu, Director General of the Confederation of Asia-Pacific Chambers of Commerce and Industry, to discuss the implications and potential ripple effects.

Others

2026/04/09Taiwan's top diplomat leads business delegation to Marshall Islands

2026/04/09Iran Rejects US Proposal as Trump Threatens Sweeping Destruction

2026/04/09President Lai reiterates 4 pillars of peace at Nylon Cheng memorial

2026/04/09Beijing's Gray-Zone Enforcers in East Asian Waters

2026/04/09Taiwan an indispensable partner amid global supply chain shift: Expert

2026/04/09Fuel surcharges soar, but not enough to cover costs, airlines say